{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:37:28Z","timestamp":1792618648795,"version":"4.5.0"},"reference-count":180,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Congestion and fluid retention are the hallmarks of decompensated heart failure and the major reason for the hospitalization of patients with heart failure. Diuretics have been used in heart failure for decades, and they remain the backbone of the contemporary management of heart failure. Loop diuretics is the preferred diuretic, and it has been given a class I recommendation by clinical guidelines for the relief of congestion symptoms. Although loop diuretics have been used virtually among all patients with acute decompensated heart failure, there is still very limited clinical evidence to guide the optimized diuretics use. This is a sharp contrast to the rapidly growing evidence of the rest of the guideline-directed medical therapy of heart failure and calls for further studies. The loop diuretics possess a unique pharmacology and pharmacokinetics that lay the ground for different strategies to increase diuretic efficiency. However, many of these approaches have not been evaluated in randomized clinical trials. In recent years, a stepped and protocolized diuretics dosing has been suggested to have superior benefits over an individual clinician-based strategy. Diuretic resistance has been a major challenge to decongestion therapy for patients with heart failure and is associated with a poor clinical prognosis. Recently, therapy options have emerged to help overcome diuretic resistance to loop diuretics and have been evaluated in randomized clinical trials. In this review, we aim to provide a comprehensive review of the pharmacology and clinical use of loop diuretics in the context of heart failure, with attention to its side effects, and adjuncts, as well as the challenges and future direction.<\/jats:p>","DOI":"10.3390\/jcm13154470","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:08:34Z","timestamp":1722359314000},"page":"4470","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Diuretic Treatment in Heart Failure: A Practical Guide for Clinicians"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-5040","authenticated-orcid":false,"given":"Lingling","family":"Wu","sequence":"first","affiliation":[{"name":"Cardiovascular Division, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"John T. Milliken Department of Medicine, Division of Cardiovascular Disease, Section of Advanced Heart Failure and Transplant, Barnes-Jewish Hospital, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"El Hachem","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayakrit","family":"Krittanawong","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Cardiology Division, NYU Langone Health and NYU School of Medicine, 550 First Avenue, New York, NY 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41569-020-0379-7","article-title":"Congestion in heart failure: A contemporary look at physiology, diagnosis and treatment","volume":"17","author":"Boorsma","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_3","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion\u2014A position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.21037\/cdt-20-302","article-title":"Pathophysiology of heart failure","volume":"11","author":"Schwinger","year":"2021","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2215\/CJN.12391213","article-title":"Integrated control of Na transport along the nephron","volume":"10","author":"Palmer","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"F279","DOI":"10.1152\/ajprenal.00073.2007","article-title":"Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice","volume":"293","author":"Oppermann","year":"2007","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_10","first-page":"F1466","article-title":"Direct evidence for apical Na+:2Cl-:K+ cotransport in macula densa cells","volume":"258","author":"Lapointe","year":"1990","journal-title":"Am. J. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-201X.2004.01320.x","article-title":"Mechanisms for macula densa cell release of renin","volume":"181","author":"Persson","year":"2004","journal-title":"Acta Physiol. Scand."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchf.2014.09.003","article-title":"Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure","volume":"3","author":"Mentz","year":"2015","journal-title":"JACC Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1681\/ASN.2016111178","article-title":"Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure","volume":"28","author":"Rao","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1527-5299.2003.02399.x","article-title":"Pharmacotherapy in congestive heart failure: Drug absorption in the management of congestive heart failure: Loop diuretics","volume":"9","author":"Sica","year":"2003","journal-title":"Congest. Heart Fail."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1002\/ehf2.13525","article-title":"Association between intestinal oedema and oral loop diuretic resistance in hospitalized patients with acute heart failure","volume":"8","author":"Ikeda","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199834010-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of torasemide","volume":"34","author":"Knauf","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5049\/EBP.2015.13.1.17","article-title":"Loop Diuretics in Clinical Practice","volume":"13","author":"Oh","year":"2015","journal-title":"Electrolytes Blood Press."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: A systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2215\/CJN.09630818","article-title":"Clinical Pharmacology in Diuretic Use","volume":"14","author":"Ellison","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic Therapy for Patients with Heart Failure: JACC State-of-the-Art Review","volume":"75","author":"Felker","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.1987.246","article-title":"Comparison of loop diuretics in patients with chronic renal insufficiency","volume":"32","author":"Voelker","year":"1987","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCHEARTFAILURE.108.821785","article-title":"Loop diuretics in acute decompensated heart failure: Necessary? Evil? A necessary evil?","volume":"2","author":"Felker","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/eurheartj\/ehad341","article-title":"Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics","volume":"44","author":"Yeoh","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","article-title":"Loop diuretic efficiency: A metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure","volume":"7","author":"Testani","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cardfail.2015.07.007","article-title":"Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure","volume":"22","author":"Grodin","year":"2016","journal-title":"J. Card. Fail."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e002370","DOI":"10.1161\/CIRCHEARTFAILURE.115.002370","article-title":"Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients with Heart Failure","volume":"9","author":"Testani","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cardfail.2018.01.009","article-title":"Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit","volume":"24","author":"Brinkley","year":"2018","journal-title":"J. Card. Fail."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cardfail.2014.03.006","article-title":"Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure","volume":"20","author":"Singh","year":"2014","journal-title":"J. Card. Fail."},{"key":"ref_31","first-page":"e011105","article-title":"Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study","volume":"17","author":"Dauw","year":"2024","journal-title":"Circ. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy","volume":"12","author":"Valente","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/1060028016637385","article-title":"Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure","volume":"50","author":"Woodruff","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijcard.2022.06.030","article-title":"Impact of transitioning patients to oral diuretics 24 hours before discharge from heart failure hospitalization on 30 day outcomes","volume":"364","author":"Epstein","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_35","first-page":"e010206","article-title":"In-Hospital Observation on Oral Diuretics after Treatment for Acute Decompensated Heart Failure: Evaluating the Utility","volume":"16","author":"Rao","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jacc.2012.12.043","article-title":"Dominance of furosemide for loop diuretic therapy in heart failure: Time to revisit the alternatives?","volume":"61","author":"Bikdeli","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1388-9842(03)00150-8","article-title":"Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV\u2014Efficacy and quality of life","volume":"5","author":"Muller","year":"2003","journal-title":"Eur. J. Heart Fail."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: Results of the TORIC study","volume":"4","author":"Cosin","year":"2002","journal-title":"Eur. J. Heart Fail."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1001\/jama.2022.23924","article-title":"Effect of Torsemide vs Furosemide after Discharge on All-Cause Mortality in Patients Hospitalized with Heart Failure: The TRANSFORM-HF Randomized Clinical Trial","volume":"329","author":"Mentz","year":"2023","journal-title":"JAMA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10557-016-6697-7","article-title":"Cardiac Dysfunction, Congestion and Loop Diuretics: Their Relationship to Prognosis in Heart Failure","volume":"30","author":"Pellicori","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1093\/eurheartj\/ehz554","article-title":"Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: A double-blind, multicentre, randomized trial","volume":"40","author":"Rohde","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/ehf2.14749","article-title":"Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure","volume":"11","author":"Croset","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ejhf.2503","article-title":"Practical outpatient management of worsening chronic heart failure","volume":"24","author":"Girerd","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.cardfail.2019.10.015","article-title":"Ambulatory Treatment of Worsening Heart Failure with Intravenous Loop Diuretics: A Four-Year Experience","volume":"26","author":"Buckley","year":"2020","journal-title":"J. Card. Fail."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2015.06.017","article-title":"Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit","volume":"4","author":"Buckley","year":"2016","journal-title":"JACC Heart Fail."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ehf2.12677","article-title":"Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: A systematic review of the literature","volume":"7","author":"Wierda","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/bdd.2510070602","article-title":"Pharmacokinetics of the thiazide diuretics","volume":"7","author":"Welling","year":"1986","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jchf.2019.09.012","article-title":"Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial","volume":"8","author":"Cox","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: The CLOROTIC trial","volume":"44","author":"Trullas","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e009149","DOI":"10.1161\/JAHA.118.009149","article-title":"Outcomes Associated with a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis","volume":"7","author":"Houser","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/13543776.2018.1523897","article-title":"Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas","volume":"28","author":"Supuran","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","article-title":"Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure","volume":"76","author":"Wilcox","year":"2020","journal-title":"Hypertension"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in Acute Decompensated Heart Failure with Volume Overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1093\/eurheartj\/ehad557","article-title":"Renal function and decongestion with acetazolamide in acute decompensated heart failure: The ADVOR trial","volume":"44","author":"Meekers","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/eurheartj\/ehad236","article-title":"Pre-treatment bicarbonate levels and decongestion by acetazolamide: The ADVOR trial","volume":"44","author":"Martens","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"(1996). Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am. J. Cardiol., 78, 902\u2013907.","DOI":"10.1016\/S0002-9149(96)00465-1"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","article-title":"Sodium retention in heart failure and cirrhosis: Potential role of natriuretic doses of mineralocorticoid antagonist?","volume":"2","author":"Bansal","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.amjcard.2014.05.062","article-title":"Effect of spironolactone on 30-day death and heart failure rehospitalization (from the COACH Study)","volume":"114","author":"Maisel","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/ki.2010.276","article-title":"Vasopressin regulation of renal sodium excretion","volume":"78","author":"Stockand","year":"2010","journal-title":"Kidney Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8B","DOI":"10.1016\/j.amjcard.2005.03.003","article-title":"Neurohormonal activation in congestive heart failure and the role of vasopressin","volume":"95","author":"Chatterjee","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ehf2.12088","article-title":"Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure","volume":"3","author":"Jujo","year":"2016","journal-title":"ESC Heart Fail."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ejhf.2001","article-title":"Cardiac output improvement by pecavaptan: A novel dual-acting vasopressin V1a\/V2 receptor antagonist in experimental heart failure","volume":"23","author":"Mondritzki","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"F889","DOI":"10.1152\/ajprenal.00267.2015","article-title":"Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus","volume":"309","author":"Norton","year":"2015","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2024.02.020","article-title":"Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients with Heart Failure","volume":"83","author":"Marton","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1681\/ASN.2020071029","article-title":"Empagliflozin Inhibits Proximal Tubule NHE3 Activity, Preserves GFR, and Restores Euvolemia in Nondiabetic Rats with Induced Heart Failure","volume":"32","author":"Benetti","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.122.059038","article-title":"Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients with Acute Decompensated Heart Failure (EMPAG-HF)","volume":"146","author":"Schulze","year":"2022","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: A multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2024.02.009","article-title":"Efficacy and Safety of Dapagliflozin in Patients with Acute Heart Failure","volume":"83","author":"Cox","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Mariani, M.V., Manzi, G., Pierucci, N., Laviola, D., Piro, A., D\u2019Amato, A., Filomena, D., Matteucci, A., Severino, P., and Miraldi, F. (2024). SGLT2i effect on atrial fibrillation: A network meta-analysis of randomized controlled trials. J. Cardiovasc. Electrophysiol.","DOI":"10.1111\/jce.16344"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes Diabetes Work Group (2022). KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int., 102, S1\u2013S127.","DOI":"10.1016\/j.kint.2022.06.008"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am. Heart J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00003246-200004000-00002","article-title":"Comparison of the renal effects of low to high doses of dopamine and dobutamine in critically ill patients: A single-blind randomized study","volume":"28","author":"Ichai","year":"2000","journal-title":"Crit. Care Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e002593","DOI":"10.1161\/CIRCHEARTFAILURE.115.002593","article-title":"Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure with Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure)","volume":"9","author":"Wan","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ejhf.2814","article-title":"Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology","volume":"25","author":"Gustafsson","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Digitalis Investigation Group (1997). The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med., 336, 525\u2013533.","DOI":"10.1056\/NEJM199702203360801"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.amjcard.2012.02.028","article-title":"Therapeutic ranges of serum digoxin concentrations in patients with heart failure","volume":"109","author":"Goldberger","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2125.2010.03687.x","article-title":"Risk of digoxin intoxication in heart failure patients exposed to digoxin-diuretic interactions: A population-based study","volume":"70","author":"Wang","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","article-title":"A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation","volume":"6","author":"Abraham","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2215\/CJN.08580813","article-title":"Regulation of Potassium Homeostasis","volume":"10","author":"Palmer","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_90","first-page":"F197","article-title":"Control of magnesium transport in the thick ascending limb","volume":"256","author":"Quamme","year":"1989","journal-title":"Am. J. Physiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1388-9842(01)00234-3","article-title":"Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure","volume":"4","author":"Milionis","year":"2002","journal-title":"Eur. J. Heart Fail."},{"key":"ref_92","first-page":"76","article-title":"Signs and symptoms of electrolyte disorders","volume":"43","author":"Weiner","year":"1970","journal-title":"Yale J. Biol. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.jacc.2020.04.021","article-title":"Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review","volume":"75","author":"Ferreira","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.113.000792","article-title":"Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)","volume":"7","author":"Rossignol","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1093\/eurheartj\/ehac401","article-title":"Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: The DIAMOND trial","volume":"43","author":"Butler","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/archinte.167.18.1998","article-title":"Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial","volume":"167","author":"Gheorghiade","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2014.12.010","article-title":"Hyponatremia in acute decompensated heart failure: Depletion versus dilution","volume":"65","author":"Verbrugge","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI40145","article-title":"The Na+-dependent chloride-bicarbonate exchanger SLC4A8 mediates an electroneutral Na+ reabsorption process in the renal cortical collecting ducts of mice","volume":"120","author":"Leviel","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ana.410130303","article-title":"Central pontine myelinolysis following rapid correction of hyponatremia","volume":"13","author":"Laureno","year":"1983","journal-title":"Ann. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ehf2.12264","article-title":"Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure","volume":"5","author":"Shirakabe","year":"2018","journal-title":"ESC Heart Fail."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardfail.2007.04.008","article-title":"Worsening renal function and prognosis in heart failure: Systematic review and meta-analysis","volume":"13","author":"Damman","year":"2007","journal-title":"J. Card. Fail."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1054\/jcaf.2002.125289","article-title":"The prognostic importance of different definitions of worsening renal function in congestive heart failure","volume":"8","author":"Gottlieb","year":"2002","journal-title":"J. Card. Fail."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: An updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ahj.2018.07.019","article-title":"Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial","volume":"204","author":"Fudim","year":"2018","journal-title":"Am. Heart J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cardfail.2016.06.423","article-title":"Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial","volume":"22","author":"Brisco","year":"2016","journal-title":"J. Card. Fail."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/08860220701641777","article-title":"Acute effect of furosemide on glomerular filtration rate in diastolic dysfunction","volume":"29","author":"Trivedi","year":"2007","journal-title":"Ren. Fail."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.117.030112","article-title":"Worsening Renal Function in Patients with Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated with Tubular Injury","volume":"137","author":"Ahmad","year":"2018","journal-title":"Circulation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ejhf.2471","article-title":"Renal effects of guideline-directed medical therapies in heart failure: A consensus document from the Heart Failure Association of the European Society of Cardiology","volume":"24","author":"Mullens","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1614329","article-title":"Single-Nephron Glomerular Filtration Rate in Healthy Adults","volume":"376","author":"Denic","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ehf2.12414","article-title":"Worsening renal failure in patients with acute heart failure: The importance of cardiac biomarkers","volume":"6","author":"Shirakabe","year":"2019","journal-title":"ESC Heart Fail."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1388-9842(02)00086-7","article-title":"The management of hyperuricemia and gout in patients with heart failure","volume":"4","author":"Spieker","year":"2002","journal-title":"Eur. J. Heart Fail."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/art.38203","article-title":"Use of diuretics and risk of incident gout: A population-based case-control study","volume":"66","author":"Bruderer","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Ritter, F., Franzeck, F., Geisshardt, J., Walker, U.A., and Osthoff, M. (2022). Gout Arthritis During Admission for Decompensated Heart Failure-A Descriptive Analysis of Risk Factors, Treatment and Prognosis. Front. Med., 9.","DOI":"10.3389\/fmed.2022.789414"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Drug and Therapeutics Bulletin (2018). Latest guidance on the management of gout. BMJ, 362, k2893.","DOI":"10.1136\/bmj.k2893"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jaip.2019.05.034","article-title":"Sulfonamide Hypersensitivity: Fact and Fiction","volume":"7","author":"Khan","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0002-9149(71)90438-3","article-title":"Ethacrynic acid and furosemide. Diuretic and hemodynamic effects and clinical uses","volume":"27","author":"Kim","year":"1971","journal-title":"Am. J. Cardiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa022963","article-title":"Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics","volume":"349","author":"Strom","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.joto.2016.10.001","article-title":"Ototoxic effects and mechanisms of loop diuretics","volume":"11","author":"Ding","year":"2016","journal-title":"J. Otol."},{"key":"ref_120","first-page":"90","article-title":"High dose frusemide in acute renal failure: A controlled trial","volume":"15","author":"Brown","year":"1981","journal-title":"Clin. Nephrol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-91-5-744","article-title":"Furosemide-induced ototoxicity","volume":"91","author":"Gallagher","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"ref_122","first-page":"CD003178","article-title":"Continuous infusion versus bolus injection of loop diuretics in congestive heart failure","volume":"2005","author":"Salvador","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCHEARTFAILURE.111.966242","article-title":"Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: Impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula","volume":"5","author":"McAlister","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrneph.2011.175","article-title":"Diuretic use in renal disease","volume":"8","author":"Sica","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"F729","DOI":"10.1152\/ajprenal.00407.2020","article-title":"Salt-sensitive hypertension in chronic kidney disease: Distal tubular mechanisms","volume":"319","author":"Bovee","year":"2020","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa2110730","article-title":"Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease","volume":"385","author":"Agarwal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/j.ajkd.2016.01.008","article-title":"Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study","volume":"68","author":"Obi","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","article-title":"Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study","volume":"12","author":"Bargman","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1523-1755.2001.0590031128.x","article-title":"Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis","volume":"59","author":"Medcalf","year":"2001","journal-title":"Kidney Int."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Palazzuoli, A., Ruocco, G., Severino, P., Gennari, L., Pirrotta, F., Stefanini, A., Tramonte, F., Feola, M., Mancone, M., and Fedele, F. (2021). Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart Failure. J. Clin. Med., 10.","DOI":"10.3390\/jcm10184207"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15420\/cfr.2015:24:2","article-title":"Decompensated Heart Failure in Pregnancy","volume":"2","author":"Anthony","year":"2016","journal-title":"Card. Fail. Rev."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0140-6736(14)60696-6","article-title":"Global, regional, and national levels and causes of maternal mortality during 1990\u20132013: A systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Kassebaum","year":"2014","journal-title":"Lancet"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Bauersachs","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jacc.2016.05.048","article-title":"High-Risk Cardiac Disease in Pregnancy: Part I","volume":"68","author":"Elkayam","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","article-title":"Use of Medication for Cardiovascular Disease During Pregnancy: JACC State-of-the-Art Review","volume":"73","author":"Halpern","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.290.6461.17","article-title":"Overview of randomised trials of diuretics in pregnancy","volume":"290","author":"Collins","year":"1985","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","article-title":"When drug therapy gets old: Pharmacokinetics and pharmacodynamics in the elderly","volume":"38","author":"Turnheim","year":"2003","journal-title":"Exp. Gerontol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ackd.2015.08.004","article-title":"Structural and Functional Changes with the Aging Kidney","volume":"23","author":"Denic","year":"2016","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000180731","article-title":"The influence of age on the renal response to water deprivation in man","volume":"17","author":"Rowe","year":"1976","journal-title":"Nephron"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM198409203111202","article-title":"Reduced thirst after water deprivation in healthy elderly men","volume":"311","author":"Phillips","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00002512-199506030-00005","article-title":"Drug-induced orthostatic hypotension in older patients","volume":"6","author":"Mets","year":"1995","journal-title":"Drugs Aging"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.gerinurse.2023.05.009","article-title":"The association between diuretics and falls in older adults: A systematic review and meta-analysis","volume":"52","author":"Bai","year":"2023","journal-title":"Geriatr. Nurs."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.158.10.1108","article-title":"NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics","volume":"158","author":"Heerdink","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure with Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/ehf2.13453","article-title":"Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction","volume":"8","author":"He","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.amjcard.2008.05.058","article-title":"Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions","volume":"102","author":"Abramov","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.3909\/ricm0602","article-title":"Contribution of right ventricular dysfunction to heart failure mortality: A meta-analysis","volume":"13","author":"Garrote","year":"2012","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ejhf.1029","article-title":"Right heart dysfunction and failure in heart failure with preserved ejection fraction: Mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Gorter","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ejheart.2007.03.001","article-title":"Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure","volume":"9","author":"Kjaergaard","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ejhf.478","article-title":"Contemporary management of acute right ventricular failure: A statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology","volume":"18","author":"Harjola","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.15420\/cfr.2019.15.2","article-title":"Right Ventricular Failure: Pathophysiology, Diagnosis and Treatment","volume":"5","author":"Arrigo","year":"2019","journal-title":"Card. Fail. Rev."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J. Heart. Lung Transplant."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1002\/ehf2.14467","article-title":"Diuretic dose is a strong prognostic factor in ambulatory patients awaiting heart transplantation","volume":"10","author":"Baudry","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0002-9149(85)90406-0","article-title":"Systemic hypertension after cardiac transplantation: Effect of cyclosporine on the renin-angiotensin-aldosterone system","volume":"56","author":"Bellet","year":"1985","journal-title":"Am. J. Cardiol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0735-1097(95)00467-X","article-title":"Breakdown of blood pressure and body fluid homeostasis in heart transplant recipients","volume":"27","author":"Braith","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/S0041-1345(97)00825-7","article-title":"Effect of FK506 on magnesium homeostasis after renal transplantation","volume":"29","author":"Niederstadt","year":"1997","journal-title":"Transplant. Proc."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1523-1755.2000.00169.x","article-title":"Interaction of cyclosporine and FK506 with diuretics in transplant patients","volume":"58","author":"Arthur","year":"2000","journal-title":"Kidney Int."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","article-title":"Diuretic therapy and resistance in congestive heart failure","volume":"96","author":"Ellison","year":"2001","journal-title":"Cardiology"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11739-018-02019-7","article-title":"Prevalence and outcome of diuretic resistance in heart failure","volume":"14","author":"Trullas","year":"2019","journal-title":"Intern. Emerg. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"15","DOI":"10.34067\/KID.0005562022","article-title":"A Machine Learning Model to Predict Diuretic Resistance","volume":"4","author":"Mercier","year":"2023","journal-title":"Kidney360"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11897-023-00617-x","article-title":"The Association Between Intra-abdominal Pressure and Diuretic Response in Heart Failure","volume":"20","year":"2023","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcrc.2013.10.004","article-title":"Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: A meta-analysis","volume":"29","author":"Kitsios","year":"2014","journal-title":"J. Crit. Care"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2215\/CJN.16041219","article-title":"Metabolic Alkalosis: A Brief Pathophysiologic Review","volume":"15","author":"Emmett","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40119-020-00194-3","article-title":"Hypochloraemia in Patients with Heart Failure: Causes and Consequences","volume":"9","author":"Cuthbert","year":"2020","journal-title":"Cardiol. Ther."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e003180","DOI":"10.1161\/CIRCHEARTFAILURE.116.003180","article-title":"Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights","volume":"9","author":"Hanberg","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12933-023-01946-w","article-title":"Lack of durable natriuresis and objective decongestion following SGLT2 inhibition in randomized controlled trials of patients with heart failure","volume":"22","author":"Packer","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Polyzogopoulou, E., Bezati, S., Karamasis, G., Boultadakis, A., and Parissis, J. (2023). Early Recognition and Risk Stratification in Cardiogenic Shock: Well Begun Is Half Done. J. Clin. Med., 12.","DOI":"10.3390\/jcm12072643"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jchf.2017.09.023","article-title":"Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey","volume":"6","author":"Girerd","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCHEARTFAILURE.112.969246","article-title":"Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure","volume":"6","author":"Kociol","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am. Heart J."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jacc.2013.05.027","article-title":"Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: Importance of sustained decongestion","volume":"62","author":"Testani","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","article-title":"Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival","volume":"122","author":"Testani","year":"2010","journal-title":"Circulation"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10741-014-9442-y","article-title":"BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: A systematic review","volume":"19","author":"Santaguida","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jchf.2022.12.001","article-title":"Successful Decongestion as a Clinical Target, Performance Indicator, and as a Study Endpoint in Hospitalized Heart Failure Patients","volume":"11","author":"Bozkurt","year":"2023","journal-title":"JACC Heart Fail."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","article-title":"Haemodynamic-guided management of heart failure (GUIDE-HF): A randomised controlled trial","volume":"398","author":"Lindenfeld","year":"2021","journal-title":"Lancet"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/15\/4470\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:26:50Z","timestamp":1760110010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/15\/4470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":180,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["jcm13154470"],"URL":"https:\/\/doi.org\/10.3390\/jcm13154470","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]}}}